GREM1 and Miyoshi myopathy: Preliminary in vitro studies demonstrated anti-Grem1 antibody treatment resulted in only a limited reduction in MM PC growth when added to MM PC stromal co-cultures and, therefore, that MM PCs do not appear to be completely dependent on Grem1 for their growth and survival.